ArticleCase reports in hematology2026
Aplastic Anemia Proceeding to Thymoma: A Rare Co-Occurrence-A Case Report and Review Article.
Article in Case reports in hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Aplastic Anemia Proceeding to Thymoma: A Rare Co-Occurrence-A Case Report and Review Article.Case reports in hematology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malignant thymoma is a rare tumor associated with various paraneoplastic syndromes, such as myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. Aplastic anemia (AA) is an uncommon complication of thymoma that may occur during the disease or after thymoma resection. We report a case presented with AA before the thymoma. Case: We report the case of a 34-year-old man with thymoma who developed AA before the detection of the tumor. Although pancytopenia did not improve after thymectomy, prolonged immunosuppressive therapy led to complete resolution of AA. The patient has no recurrence during a 42-month follow-up period. Conclusion: AA may precede the detection of thymoma and represent its initial clinical manifestation. So, thymoma should be considered a rare cause, along with other more common etiologies of AA. Patients with AA and thymoma require prolonged immunosuppressive therapy after surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.